Tivic Health Systems, Inc. (TIVC)

Market Cap	2.17M
Revenue (ttm)	780,000
Net Income (ttm)	-5.66M
Shares Out	620.14K
EPS (ttm)	-19.68
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	117,730
Open	3.600
Previous Close	3.680
Day's Range	3.490 - 3.750
52-Week Range	2.430 - 31.450
Beta	2.16
Analysts	n/a
Price Target	n/a
Earnings Date	May 14, 2025

About TIVC

Tivic Health Systems, Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus pain, pressure, and congestion. The company sells its products on online retailers, commercial distributors, and through its own websites; The company’s lead product include Entolimo, a biologic program focuses on immunotherapeutics is the late-stage TLR5 agonist for the treatment of acute radiation syndrome. In addition, it markets com...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Nov 11, 2021
• Employees: 7
• Stock Exchange: NASDAQ
• Ticker Symbol: TIVC
• Website: https://tivichealth.com

Financial Performance

In 2024, Tivic Health Systems's revenue was $780,000, a decrease of -33.67% compared to the previous year's $1.18 million. Losses were -$5.66 million, -31.40% less than in 2023.